We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$508M
1-Year Est. Return
14.21%
This Fund
S&P 500
This Quarter
Est. Return
+8.18%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$271M
AUM Growth
+$14.9M
(+5.8%)
Cap. Flow
-$3.08M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
101
New
10
Increased
26
Reduced
33
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.41M |
| 2 |
Cerence
CRNC
|
+$894K |
| 3 |
Keysight
KEYS
|
+$734K |
| 4 |
Omnicom Group
OMC
|
+$427K |
| 5 |
Kinder Morgan
KMI
|
+$423K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$10.1M |
| 2 |
Tapestry
TPR
|
+$3.33M |
| 3 |
ExxonMobil
XOM
|
+$291K |
| 4 |
3M
MMM
|
+$230K |
| 5 |
Automatic Data Processing
ADP
|
+$199K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.26% |
| 2 | Healthcare | 17.57% |
| 3 | Financials | 17.49% |
| 4 | Consumer Discretionary | 15.03% |
| 5 | Communication Services | 8.65% |
Similar funds
MCM
MC
OA
MCA
WMG
PWMG
RFG
PP
McRae Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, McRae Capital Management held 101 positions worth $271M, up 5.8% from $257M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
McRae Capital Management's Q4 2019 filing shows 10 new, 26 increased, 33 reduced and 3 closed positions. Its largest new stake was Cerence: 54,517 shares worth $1.23M. The largest sale was Celgene Corp, an estimated $10.1M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- McRae Capital Management's largest Q4 2019 buy was Cerence: 54,517 shares worth $1.23M.
- McRae Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $6.41M increase.
- McRae Capital Management's biggest Q4 2019 reduction was ExxonMobil, cutting an estimated $291K.
- McRae Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $10.1M.
- McRae Capital Management's ten largest holdings make up 42% of its $271M portfolio in Q4 2019.
- McRae Capital Management opened 10 new positions and closed 3 in Q4 2019.
- McRae Capital Management's portfolio value rose 5.8% quarter-over-quarter to $271M.
Based on McRae Capital Management's 13F filing for Q4 2019, filed 17 Jan 2020.